KDP Q4 diluted EPS hits USD 0.26 on 3.4x jump

Reuters
02/24
KDP Q4 diluted EPS hits USD 0.26 on 3.4x jump

Keurig Dr Pepper reported Q4 2025 net sales of USD 4.5 billion (+10.5%) and diluted EPS of USD 0.26; on an adjusted basis, Q4 diluted EPS was USD 0.60 (+1.7%). Q4 2025 net income was USD 353 million, operating income was USD 881 million, operating cash flow was USD 712 million, and free cash flow was USD 564 million. For FY 2025, Keurig Dr Pepper posted net sales of USD 16.6 billion (+8.2%) and diluted EPS of USD 1.53 (+45.7%); on an adjusted basis, FY diluted EPS was USD 2.05 (+7.3%). FY 2025 net income was USD 2.1 billion, operating income was USD 3.6 billion, operating cash flow was USD 2.0 billion, and free cash flow was USD 1.5 billion. Segment net sales in FY 2025 were USD 10.4 billion for U.S. Refreshment Beverages (+11.9%), USD 4.0 billion for U.S. Coffee (+0.6%), and USD 2.2 billion for International (+5.9%); Q4 segment net sales were USD 2.7 billion (+11.5%), USD 1.2 billion (+3.9%), and USD 604 million (+21.0%), respectively. The company highlighted momentum in U.S. Refreshment Beverages and noted the GHOST acquisition contributed to volume/mix growth in both Q4 and FY 2025. Keurig Dr Pepper also provided a 2026 outlook calling for net sales of USD 25.9 billion to USD 26.4 billion and adjusted diluted EPS growth in a low-double-digit range, reflecting an incremental contribution from JDE Peet’s assuming an early April close. Separately, the board chair role is set to transition from Bob Gamgort to Pamela Patsley at the end of Q1 2026, with Gamgort stepping off the board at that time.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Keurig Dr Pepper Inc. published the original content used to generate this news brief on February 24, 2026, and is solely responsible for the information contained therein.

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10